Results 41 to 50 of about 41,451 (188)

Spontaneous Tumor Lysis Syndrome in Small Cell Lung Cancer. [PDF]

open access: yesCureus, 2017
Tumor lysis syndrome (TLS) is a life-threatening oncologic complication caused by the lysis of a vast number of malignant cells resulting in metabolic derangements and organ dysfunction. TLS can occur spontaneously before initiation of any therapies often referred to as spontaneous tumor lysis syndrome (STLS), or shortly after the induction of ...
Kanchustambham, Venkatkiran   +3 more
openaire   +4 more sources

Fatal Spontaneous Tumor Lysis Syndrome in a Patient with Metastatic Colon Cancer: A Clinical Case of Rare Oncological Emergency

open access: yesCase Reports in Gastroenterology, 2020
Tumor lysis syndrome (TLS) is a potentially life-threatening complication of chemotherapy. It usually occurs in rapidly proliferating hematological malignancies. TLS is deemed spontaneous (STLS) when it occurs prior to any cytotoxic or definite treatment.
Inna Shaforostova   +4 more
doaj   +1 more source

Fatal tumor lysis syndrome in a patient with metastatic gastric adenocarcinoma [PDF]

open access: yes, 2020
Tumor lysis syndrome is a well-characterized and potentially deadly complication of spontaneous or treatment-related tumor destruction, and it is most commonly associated with hematologic malignancies.
Felty, Cameron   +2 more
core   +3 more sources

Spontaneous tumor lysis syndrome in a patient of chronic lymphocytic leukemia [PDF]

open access: yesIndian Journal of Medical and Paediatric Oncology, 2014
Ajay Gogia   +3 more
doaj   +3 more sources

Tumor lysis syndrome in an extraskeletal osteosarcoma: a case report and review of the literature [PDF]

open access: yes, 2017
BACKGROUND: This case report describes a spontaneous tumor lysis syndrome due to a rare solid tumor. CASE PRESENTATION: A 65-year-old white woman had tumor lysis syndrome, which represent a dangerous oncological emergency.
Giulia Malaguarnera   +5 more
core   +1 more source

The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network [PDF]

open access: yes, 2013
Background: Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces adverse events (AE) in up to 64% of patients.
A Bashey   +88 more
core   +10 more sources

Spontaneous acute tumor lysis syndrome with advanced gastric cancer [PDF]

open access: yesJournal of Korean Medical Science, 2001
Acute tumor lysis syndrome (TLS) occurs frequently in hematologic malignancies such as high-grade lymphomas and acute leukemia, which are rapidly proliferating and chemosensitive tumors. It occurs rarely in solid tumors and has never been reported in gastric adenocarcinoma.
I S, Woo   +11 more
openaire   +2 more sources

Acute kidney injury in critically ill cancer patients : an update [PDF]

open access: yes, 2016
Patients with cancer represent a growing group among actual ICU admissions (up to 20 %). Due to their increased susceptibility to infectious and noninfectious complications related to the underlying cancer itself or its treatment, these patients ...
Benoit, Dominique   +3 more
core   +2 more sources

Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer's mouse model [PDF]

open access: yes, 2020
Background Diabetes is a risk factor for developing Alzheimer's disease (AD); however, the mechanism by which diabetes can promote AD pathology remains unknown.
Fernández Ponce, Cecilia Matilde   +7 more
core   +3 more sources

Spontaneous self-alkalinization in spontaneous tumor lysis syndrome [PDF]

open access: yesKidney International, 2006
A 64-year-old white male presented to the hospital with a scrotal mass, diffuse pelvic lymphadenopathy, and right hydronephrosis due to a diffuse large B-cell lymphoma. He was also found to have a left staghorn calculus. The patient was treated with a right orchiectomy and placement of a right-sided ureteral stent.
openaire   +2 more sources

Home - About - Disclaimer - Privacy